OBJECTIVE -To provide an overview of the Department of Veterans Affairs (VA) research activities, highlighting diabetes-related research.
A
high priority of the Department of Veterans Affairs (VA) is research. The VA Office of Research and Development is dedicated to discovering new knowledge, creating innovations that translate into advances in health care for veterans and the nation, and developing VA researchers and health care leaders. This article provides an overview of diabetes research within the VA.
The VA research program began after World War II. In affiliated hospitals, physicians cared for patients, taught medical students and residents, and engaged in their own research. In 2003, the VA research program received $394 million in VA funds, with an additional $400 million in indirect research support from VA medical appropriations. An additional $565 million in direct support come from other non-VA research funds for a total annual budget of nearly $1.4 billion (Table 1). The funding available to VA researchers has increased considerably from FY1997 to the projected budget for FY2004. Collaboration with nongovernment agencies, private foundations, and private industry leverages VA research resources and contributes to productive interagency working relationships. The VA research program currently supports Ͼ15,000 research projects and 3,800 investigators in 115 different VA medical centers. This research involves Ͼ15,000 patients and is designed to improve the health of both veterans and nonveterans.
Diabetes is the third most common diagnosis among veterans who receive medical care from VA. Given the significant burden and opportunities for primary and secondary prevention for veterans with diabetes, the VA research program makes a substantial investment in diabetes research, spanning the continuum from basic genetics research to clinical trials on diabetes prevention and treatment (1) .
The VA offers several types of research awards. The merit review mechanism is used to fund investigator-initiated research and is similar to the National Institutes of Health R-01 funding mechanism. Career Development and Research Scientist Awards are available to support the development of promising junior and established senior investigators. The VA supports multiple centers of excellence in each of its research services. They target specific diseases, particular research methods, or areas of emphasis, such as multiple sclerosis, epidemiology research, and quality of care and utilization studies. In 2002, VA research support was allocated as follows: 70% to investigatorinitiated projects, 14% to multisite trials, 8% to Centers of Excellence (n ϭ 41), 7% to career development awardees (n ϭ 188), and 1% to service-directed research.
In The VA conducts population-based research through clinical trials on health issues that are vital to our nation's veterans. Through multisite randomized trials, VA researchers are investigating strategies to improve the effectiveness of treatment provided to persons with diabetes. Some current examples in the diabetes portfolio include studies of innovative models for diabetes care, evaluating the short-term consequences of screening for diabetes, and investigating the use of fluorescent scatter on the lens of the eye as a possible tool for diagnosing diabetes. A cooperative study is now underway using intensive versus conventional insulin treatment to manage glycemia in veterans with type 2 diabetes. This study examines the issues of expected benefits and costs and cardiovascular disease outcomes.
Other funding mechanisms are used to support peer-reviewed research, specialized centers of excellence, and training. The Epidemiologic Research and Information Centers (ERICs) conduct diabetes and other research, education, and technical assistance and disseminate relevant findings to research and clinical communities.
Between 1998 and 2002, the VA with cofunding from the Juvenile Diabetes Foundation International, created three VA diabetes research centers located in Iowa City, Nashville, and San Diego. The Iowa City focus was the identification of potential causes of early vascular defects and design of preventive or palliative therapies. The Nashville center emphasized the cellular and molecular processes by which intensive therapy reduced insulin resistance and the role of exercise in modulating therapeutic effectiveness. The San Diego center concentrated on insulin resistance mechanisms and causes of diabetic vascular and renal complications.
Biomedical Laboratory Research and Development
Biomedical Laboratory Research and Development supports investigator-initiated research to study basic biological or physiological principles related to disorders and diseases of importance to veterans. Funded programs may use human tissues, blood, or other biological specimens or animal models, but not intact human subjects. Research in Biomedical Laboratory Research and Development emphasizes projects that will ultimately lead to improvements in clinical practice. Examples of relevant diabetes research include studies on prevalence and clinical signifi- Diabetes-related research portfolio Diabetes-related research was broadly defined and investigated from FY1998 to FY2003. On an annual basis, VA investigators provide a research abstract on their research projects. We searched this research abstract system for research that included diabetes, diabetes complications, and the word "diabetes" in the title or text of the abstract or as a discrete MeSH term (c 18.452.297 and C 19.246). Table 2 provides a summary of diabetes-related research broadly defined by year, number of projects, source, and amount of funds. Research funding was awarded for pilot funding, pre-and postdoctoral training, merit review applications, career development, career scientists, and center grants. Table 2 also shows sizeable increases in both the number of VA diabetes-related research projects and the funding resources. Over this 16-year interval, non-VA-funded research projects grew Ͼ3-fold, while the supporting research dollars increased 10-fold. The strong education and training mission of the VA explains the large number of projects initiated without funding. These diabetes-related projects were conducted with existing personnel and local support or as part of an existing, funded VA research program. For example, many pre-and postdoctoral fellows and physicians in training received local assistance to conduct thesis, dissertation, and other research and thus did not need to apply for peer-reviewed research support.
The VA was the leading source of funding for diabetes-related projects. The merit review mechanism accounted for the majority of funds spent by the VA on diabetes-related research during this interval. Table 3 shows non-VA-funded research in 2003; the National Institutes of Health provided 69% of the resources, followed by nonfederal sources at 12% (state, university, and private corporations), nonprofit foundations at 11%, and other federal sources at 8%. (2) (3) (4) .
VA investigators continue to play major roles in both VA-and non-VA-funded clinical trials relevant to diabetes. Given the liberal definition we used for "diabetes-related," these findings may appear to inflate the agency's diabetes-related research. We were cognizant of the underlying mechanisms involved in diabetes pathogenesis, diagnosis, treatment, costs, and outcomes, and all were included in this search.
Other major qualitative changes that occurred during this interval were expanded collaborations between the Office of Research and Development and the Centers for Medicare and Medicaid Services, National Institutes of Health, Centers for Disease Control, the American Diabetes Association, Juvenile Diabetes Foundation, and international and private corporations. In addition, the Diabetes QUERI has become a strong research center, now stimulating and supporting an increased number of diabetes-related research projects that address gaps in VA diabetes care.
In conclusion, this article summarizes diabetes activities and funding supported by the VA Office of Research and Development and other agencies. The VA was the major source of funds to support these activities, with the National Institutes of Health providing the second largest amount. Many research projects are conducted largely in support of trainees. Diabetes-related research is conducted across all VA research services and covers the full spectrum of investigative designs, from bench research to clinical trials. The VA, with its national distribution of health care facilities; advanced clinical information systems, resources, and researchers; and large population of patients with diabetes, can anticipate an even larger future role in diabetes research.
